We have developed an in situ hybridization assay capable of detecting enteroviral RNA in myocardial cells, using molecularly cloned coxsackievirus B3 cDNA as a diagnostic probe. Because of the high degree of nucleic acid sequence homology among the numerous enteroviral serotypes, including the group A and B coxsackieviruses and the echoviruses, detection of these various agents commonly implicated in human viral heart disease is possible in a single hybridization assay. We demonstrate the considerable potential of this method for an unequivocal diagnosis of enteroviral heart disease as well as for pathogenicity studies. Using athymic mice persistently infected with coxsackievirus B3 as a model system, we show that the myocardium is affected in a disseminated, multifocal manner.
In North America and Europe, acute myocarditis is most commonly associated with infections by coxsackie B viruses (types 1 to 5). Other members of the human enteroviruses comprising at present over 70 serotypes (e.g., various coxsackie A viruses and echoviruses) are also considered to be relatively frequent causes of human viral heart disease (1-4). These agents appear to be capable of producing dilated cardiomyopathy of acute onset or lead to a variety of cardiac arrhythmias. Some of the acute cases may also evolve into a chronic form of dilated cardiomyopathy.
The difficulty of establishing a specific diagnosis of viral heart disease is a major problem in clinical cardiology. Confirmation ofthe clinical suspicion of viral heart disease demands demonstration of replicating virus inside myocardial cells, which is exceedingly difficult by conventional methods (5) . In addition, the increasing availability of potential antiviral agents has accentuated the need for methods by which endomyocardial biopsy specimens of patients with suspected viral heart disease can be diagnosed conclusively (6, 7) .
In order to introduce in situ nucleic acid hybridization (8-10) as a diagnostic tool in suspected enteroviral heart disease, we have recently cloned the single-stranded RNA genome of coxsackievirus B3 (CVB3) (11) that had been propagated in cultured human heart cells (12) . Full-length reverse-transcribed cloned viral cDNA generated infectious CVB3 upon transfection into mammalian cells, demonstrating the molecular cloning of a faithful transcript ofthe original viral RNA. We now report the use of radioactively labeled cloned CVB3 cDNA as a diagnostic probe for the in situ detection of viral RNA in infected cultured cells and in myocardial tissue sections of CVB3-infected T-cell-deficient mice. We show that the molecular hybridization approach permits the detection of infected myocardial cells at the single-cell level, thus providing a unique possibility for an unequivocal diagnosis.
A further advantage of the nucleic acid hybridization approach is provided by the high degree of genetic homology shared among the different serotypes of the human enterovirus group (11, (13) (14) (15) (16) (17) , making possible their detection in a single hybridization assay. Detection of various enteroviruses by use of subgenomic cDNA fragments has been reported (18) (19) (20) 
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Preparation of Labeled DNA Probes. The infectious CVB3 cDNA clone pCB3-M1 (11) was digested with Kpn I or BamHI restriction endonuclease to generate a 6.2-kilobase and a 1.0-kilobase fragment, respectively. These two CVB3-specific fragments represent -95% of the viral genome excluding 66 nucleotides at the 5' end and =300 nucleotides of the polyadenylylated 3' end. After the two CVB3 cDNA fragments were purified twice by agarose gel electrophoresis, they were used in different assays for nick-translation (22) under conditions to generate radiolabeled CVB3 cDNA fragments =100 nucleotides long. CVB3 cDNA fragments (200-500 ng) were incubated for 2 hr at 15'C in 20 /il of50 mM TrisHCI, pH 7.5/5 mM MgCl2/bovine serum albumin (5 Ag/ml)/10 mM 2-mercaptoethanol/20 ,uM each of the four
[3H]dNTPs Ci/mmol; 1 Ci = 37 GBq)/DNase I (0.01-0.1 ,ug/ml)/DNA polymerase I (250 units/ml). The nick-translated CVB3 cDNA fragments were isolated by phenol extraction followed by spin-column chromatography (centrifugation through a Sephadex G-50 gel-filtration column) and mixed at a molar ratio of 1:1. The specific activity of the 3H-labeled CVB3 cDNA probe was 0. were prepared from the plasmid vector p2732B (11) .
In Situ Hybridization. Before hybridization the slide preparations were treated as follows: 20 min at room temperature in 0.2 M HCI, 30 min at 70°C in 2x SSC, and 15 min at 37°C in 20 mM Tris HCl, pH 7.4/2 mM CaC12/proteinase K (1 ,ug/ml) (10). Slides were washed twice in distilled water and then dehydrated in graded ethanol solutions (70o and 95%). Hybridization mixture contained 3H-or 35S-labeled CVB3 cDNA probe (200 ng/ml, heated to 100°C for 5 min), 10 mM Tris-HCl (pH 7.4), 50% (vol/vol) deionized formamide, 600 mM NaCl, 1 mM EDTA, 0.02% polyvinylpyrrolidone, 0.02% Ficoll, 0.05% bovine serum albumin, 10% (wt/vol) dextran sulfate, 10 mM dithiothreitol, sonicated denatured calf thymus DNA (200 ,ug/ml), myocardial total RNA (1 mg/ml), and rabbit liver tRNA (200 ,g/ml). Fourteen microliters of hybridization mixture was applied to each slide, siliconized coverslips were mounted and sealed with rubber cement, and hybridization was allowed to proceed at 25°C for 48 hr. Slides were then washed for 18 hr at 37°C in 10 mM Tris-HCl, pH 7.4/2x SSC/50% formamide/1 mM EDTA followed by 1 hr at 55°C in 2x SSC, then rinsed in 2x SSC, and dehydrated in graded ethanol solutions containing 300 mM ammonium acetate. Hybridized preparations were autoradiographed with NTB2 nuclear track emulsion (Eastman) diluted 1:1 with 600 mM ammonium acetate. After exposure for indicated intervals at 4°C, slides were developed with Kodak D19 and examined unstained with a Zeiss interference contrast microscope.
RNA Blot Analysis of Enterovirus-Infected Cells. Vero cells were inoculated with different enteroviral strains (CVB1, CVB2, CVB3, CVB4, CVB5, CVB6, CVA9, echo 11, echo 12, polio type 1) at a moi of 20 pfu per cell. Total RNA of infected cells was isolated when 50% of the cells exhibited cytopathologic effects, applied in 1:10 dilution (1 ,ug, 0.1 ,ug) to nitrocellulose paper by means of a slot-blot filter apparatus, and hybridized with 32P-labeled CVB3 cDNA corresponding to the region from 0.06 to 7.2 kilobases of the viral genome (11) . CVB3 RNA isolated from suspensions of purified CVB3 was used as a positive control and loaded in the presence of total RNA from uninfected Vero cells. Purified RNA from foot-and-mouth-disease virus and total RNA from cells infected with vesicular stomatitis virus served as negative controls.
Materials (Fig. 1A) . In contrast, highly significant labeling was observed when CVB3-infected Vero cells were hybridized with the CVB3 cDNA probe. (Fig. 2G) , indicating high copy numbers of replicating viral RNA in myocardial cells.
Cloned CVB3 cDNA as an Enteroviral Diagnostic Reagent. Recent work in our laboratory (11) and elsewhere (18) (19) (20) had shown that nucleic acid hybridization using cDNA probes derived from the RNA of certain enteroviruses can recognize diverse enteroviral serotypes. To estimate the degree of nucleotide sequence homology between the numerous cardiotropic enteroviral serotypes by a slot-blot hybridization assay, Vero cells were infected with various enteroviruses at a moi of 20 pfu per cell. Total RNA of infected cultures was isolated when about 50% of cells exhibited cytopathologic effects, blotted on nitrocellulose filter in 1:10 dilutions, and hybridized with 32P-labeled CVB3 cDNA corresponding to the region from 0.06 to 7.2 kilobases of the viral genome. The results (Fig. 3) indicate a remarkably high degree of nucleotide sequence homology among different human enteroviral strains, including coxsackie B viruses (types 1 to 6), coxsackievirus A9 (CVA9), echoviruses 11 and 12, and poliovirus type 1. Because comparative nucleotide sequence data for CVB3 (11, 15, 16) and poliovirus type 1 (13, 14) show an overall homology of about 70% within functional genes (e.g., the replicase gene) or within the noncoding 5' region, these cross-hybridization data (Fig. 3) appear to predict an even higher degree of nucleotide sequence homology between the different serotypes of coxsackie A and B viruses as well as echoviruses. With respect to group B coxsackieviruses, the extent of cross-hybridization is in agreement with the recently published sequence of CVB1 (17), which indicated a homology of 85% for regions like the replicase gene of these viruses. In contrast, foot-and-mouth-disease virus, a nonhuman picornavirus or vesicular stomatitis virus do not hybridize under the conditions described. These results indicate that the complete cloned CVB3 cDNA can be used as a human enteroviral diagnostic reagent. Using a CVB3 cDNA fragment corresponding to the region from 0.88 to 2.7 kilobases of the viral genome, which encodes the viral coat proteins 1B (VP2), 1C (VP3), and parts of 1A (VP4) and 1D (VP1) (24), we found, in agreement with others (19) , that serotype-specific hybridization is possible for the CVB3
RNA (data not shown). DISCUSSION
Enteroviruses of the human Picornaviridae, such as the group A and B coxsackieviruses and the echoviruses, are generally considered to be the most common agents ofviral heart disease. However, physicians lack information on how often enteroviruses are actually the cause ofdilated cardiomyopathy, what the prognosis is in such cases, and whether specific therapy can affect prognosis. The reason for this fundamental lack of knowledge is the difficulty of obtaining an unequivocal diagnosis of suspected viral heart disease. The techniques so far used to investigate endomyocardial biopsy specimens from patients with suspected viral heart disease include electron microscopy, virus-isolation procedures, and immunohistochemistry. However, with respect to enteroviral heart disease, these techniques are limited by various methodological problems: (i) at the electron microscope level, enteroviruses are indistinguishable in density and size from ribosomes (25) ; (ii) virus-isolation procedures appear to be successful only in the acute phase of the disease with extensive virus replication (2, 5); (iii) immunohistochemistry using serotype-specific antibodies is less practicable, as is enterovirus serology, because of the high number of distinct enteroviral serotypes that might be implicated in the disease.
Using cloned CVB3 cDNA as a diagnostic reagent, detection of myocardial cells replicating enteroviral RNA is now As shown by cross-hybridization experiments, detection of the most commonly implicated agents of human viral heart disease, including group A and B coxsackieviruses as well as echoviruses, is possible in a single hybridization assay. This broad detection spectrum will greatly facilitate diagnosis of suspected enteroviral heart disease, since from the clinical point of view the antigenic typing of an etiologically implicated enteroviral strain appears to be of secondary importance and can be carried out later-e.g., by standard virological techniques or by hybridization with serotype-specific cDNA fragments.
Positive hybridization results obtained with human endomyocardial biopsy samples of patients with acute or chronic myocarditis as well as dilated cardiomyopathy indicate the general applicability of the method described for the diagnosis of enteroviral heart disease (7). It should now be possible with this technique to address a number of important questions concerning the molecular basis of pathogenicity. We are especially interested in the question of enteroviral persistence in the pathogenesis of chronic dilated cardiomyopathy evolving from acute or subacute myocardial infection.
